NCT00689858View on ClinicalTrials.gov

Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Healthy
Interventions
DRUG

Cilostazol, Ginkgo biloba and placebo

dosing time

Trial Locations (3)

Unknown

INJE University Pusan Paik Hospital, Pusan

SKChemicals, Seoul

110-744

SK chemicals, Seoul

All Listed Sponsors
lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT00689858 - Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo | Biotech Hunter | Biotech Hunter